Executing strategic priorities in the face of heightened scrutiny
Healthcare is changing fast. To stay ahead of the curve, key players across its ecosystem are pursuing strategic mergers, sales, acquisitions, and joint ventures to drive growth and improve patient care. But collaborative partnerships among competitors are gaining intense attention from regulators across the board. We’re here to help healthcare providers, hospitals and health systems, health technology companies, payors, and investors anticipate, prevent, and defend against potential antitrust challenges in the face of ever-increasing scrutiny.
Healthcare Antitrust Transactions
From M&A and private equity investments to joint ventures and strategic alliances, transactions in healthcare face a higher level of complexity and regulatory scrutiny than most. And as private equity becomes increasingly invested in healthcare, regulators across state and federal agencies – including the DOJ, FTC, state attorneys general, and other antitrust agencies, such as the European Commission – are taking notice and action. That’s why we deliver solutions informed by a deep knowledge of the complex rules and regulations and strategic challenges impacting healthcare transactions to protect your interests and maximize opportunity.
We combine extensive antitrust knowhow and unmatched PE and M&A transaction experience in a way no other firm can to help you navigate dealmaking in this dynamic landscape. For the last 14 years in a row, we have handled more M&A deals worldwide than any other law firm and advised on the most global healthcare private equity deals in 2023. We know how to tackle complex regulatory challenges while balancing investment goals in line with trends we see internationally. Beyond closing, we routinely advise portfolio companies, providing peace of mind to investors that their portfolio companies are receiving sound regulatory advice with an eye toward mitigating future risks.
Healthcare Antitrust Lawyers
Our integrated team includes seasoned antitrust lawyers that structure transactions to stand up against aggressive merger enforcement in the healthcare space. These lawyers work in federal and state courts across the country and globally and frequently represent clients before the FTC, the Antitrust Division of the Department of Justice, state attorneys general, the European Commission, and national regulators across the globe. Antitrust agencies globally are part of the International Competition Network and coordinate cases between them making an international team of antitrust lawyers imperative.
With a deep bench of former high-ranking enforcers from federal and state antitrust agencies and experienced trial lawyers that have litigated complex governmental and private antitrust cases, we maintain strong relationships with regulatory authorities around the world, which enables us to anticipate what is on the horizon and help clients seize opportunities and minimize down-side risk.
Changing Healthcare Antitrust Regulations
Beyond the objectives of a specific deal, we understand that strategic transactions are a critical piece of long-term business plans. And as healthcare continues to evolve, forward-looking insights on how decisions in Washington and internationally impact your current and future business objectives are critical to your resiliency and success. That’s why our health policy strategic consulting team provides key intelligence and strategic advice for navigating the evolving regulatory, funding, political, and policy landscapes to create roadmaps for growth in unprecedented times.
.jpg?rev=-1)
